BOSTON DR LIM

BIOTECH (112) Arcus Biosciences: Adenosine Immuno-Oncology Platform Company from Flexus Biosciences’ Spin-off by Terry Rosen and Juan Jaen

March 5, 2024March 5, 2024

BIOTECH (111) Flexus Biosciences: Treg Small Molecule Inhibitors

March 5, 2024March 5, 2024

BIOTECH (110) Gritstone Bio: self-amplifying RNA in chimpanzee adenovirus vector

March 4, 2024April 2, 2024

BIOTECH (109) MAIA Biotechnology: THIO – Telomere-Targeting Agent

March 4, 2024March 4, 2024

BIOTECH (108) Stapled Peptides: From Aileron to Fog Pharma

March 4, 2024March 4, 2024

부러우면 지는거다 (29) 최성락 경영학 박사

March 4, 2024March 4, 2024

BIOTECH (107) Sana Biotechnology의 Fusogen Platform 보류에 대한 소고

March 3, 2024March 4, 2024

BIOTECH (106) Point Biopharma: Precision Radioligand Therapy (RLT)

March 3, 2024March 3, 2024

BIOTECH (105) Entos Pharmaceuticals: Fusogenix Proteolipid Vehicle (PLV) Platform

March 3, 2024March 3, 2024

BIOTECH (104) Novartis: Pluvicto (177Lu-PSMA-617) – the First Precision Radiopharmaceuticals

March 2, 2024March 2, 2024